292 related articles for article (PubMed ID: 26334134)
1. Development of high-yield influenza A virus vaccine viruses.
Ping J; Lopes TJS; Nidom CA; Ghedin E; Macken CA; Fitch A; Imai M; Maher EA; Neumann G; Kawaoka Y
Nat Commun; 2015 Sep; 6():8148. PubMed ID: 26334134
[TBL] [Abstract][Full Text] [Related]
2. Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone.
Medina J; Boukhebza H; De Saint Jean A; Sodoyer R; Legastelois I; Moste C
Vaccine; 2015 Aug; 33(35):4221-7. PubMed ID: 26206270
[TBL] [Abstract][Full Text] [Related]
3. The PB1 segment of an influenza A virus H1N1 2009pdm isolate enhances the replication efficiency of specific influenza vaccine strains in cell culture and embryonated eggs.
Mostafa A; Kanrai P; Ziebuhr J; Pleschka S
J Gen Virol; 2016 Mar; 97(3):620-631. PubMed ID: 26743314
[TBL] [Abstract][Full Text] [Related]
4. Molecular signature of high yield (growth) influenza a virus reassortants prepared as candidate vaccine seeds.
Ramanunninair M; Le J; Onodera S; Fulvini AA; Pokorny BA; Silverman J; Devis R; Arroyo JM; He Y; Boyne A; Bera J; Halpin R; Hine E; Spiro DJ; Bucher D
PLoS One; 2013; 8(6):e65955. PubMed ID: 23776579
[TBL] [Abstract][Full Text] [Related]
5. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2015 Mar; 90(12):109-20. PubMed ID: 25796641
[No Abstract] [Full Text] [Related]
6. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
[TBL] [Abstract][Full Text] [Related]
7. 220 mutation in the hemagglutinin of avian influenza A (H7N9) virus alters antigenicity during vaccine strain development.
Liu L; Lu J; Li Z; Zhou J; Guo J; Li X; Liu J; Shu Y; Wang D
Hum Vaccin Immunother; 2018 Mar; 14(3):532-539. PubMed ID: 29300686
[TBL] [Abstract][Full Text] [Related]
8. Development of high-yield influenza B virus vaccine viruses.
Ping J; Lopes TJ; Neumann G; Kawaoka Y
Proc Natl Acad Sci U S A; 2016 Dec; 113(51):E8296-E8305. PubMed ID: 27930325
[TBL] [Abstract][Full Text] [Related]
9. A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.
Hu W; Zhang H; Han Q; Li L; Chen Y; Xia N; Chen Z; Shu Y; Xu K; Sun B
Vaccine; 2015 Jan; 33(2):374-81. PubMed ID: 25448099
[TBL] [Abstract][Full Text] [Related]
10. Improvement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34.
Pan W; Dong Z; Meng W; Zhang W; Li T; Li C; Zhang B; Chen L
Hum Vaccin Immunother; 2012 Feb; 8(2):252-9. PubMed ID: 22426370
[TBL] [Abstract][Full Text] [Related]
11. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
[TBL] [Abstract][Full Text] [Related]
12. Cloned cDNA of A/swine/Iowa/15/1930 internal genes as a candidate backbone for reverse genetics vaccine against influenza A viruses.
Lekcharoensuk P; Wiriyarat W; Petcharat N; Lekcharoensuk C; Auewarakul P; Richt JA
Vaccine; 2012 Feb; 30(8):1453-9. PubMed ID: 22230579
[TBL] [Abstract][Full Text] [Related]
13. Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase.
Broecker F; Zheng A; Suntronwong N; Sun W; Bailey MJ; Krammer F; Palese P
J Virol; 2019 Sep; 93(18):. PubMed ID: 31375573
[TBL] [Abstract][Full Text] [Related]
14. A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells.
Wen F; Li L; Zhao N; Chiang MJ; Xie H; Cooley J; Webby R; Wang PG; Wan XF
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118117
[TBL] [Abstract][Full Text] [Related]
15. Improved antigen yield in pandemic H1N1 (2009) candidate vaccine viruses with chimeric hemagglutinin molecules.
Harvey R; Guilfoyle KA; Roseby S; Robertson JS; Engelhardt OG
J Virol; 2011 Jun; 85(12):6086-90. PubMed ID: 21490098
[TBL] [Abstract][Full Text] [Related]
16. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2016 Mar; 91(11):133-43. PubMed ID: 26995804
[No Abstract] [Full Text] [Related]
17. Mutation of Influenza A Virus PA-X Decreases Pathogenicity in Chicken Embryos and Can Increase the Yield of Reassortant Candidate Vaccine Viruses.
Hussain S; Turnbull ML; Wise HM; Jagger BW; Beard PM; Kovacikova K; Taubenberger JK; Vervelde L; Engelhardt OG; Digard P
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381488
[TBL] [Abstract][Full Text] [Related]
18. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
[TBL] [Abstract][Full Text] [Related]
19. Synthetic generation of influenza vaccine viruses for rapid response to pandemics.
Dormitzer PR; Suphaphiphat P; Gibson DG; Wentworth DE; Stockwell TB; Algire MA; Alperovich N; Barro M; Brown DM; Craig S; Dattilo BM; Denisova EA; De Souza I; Eickmann M; Dugan VG; Ferrari A; Gomila RC; Han L; Judge C; Mane S; Matrosovich M; Merryman C; Palladino G; Palmer GA; Spencer T; Strecker T; Trusheim H; Uhlendorff J; Wen Y; Yee AC; Zaveri J; Zhou B; Becker S; Donabedian A; Mason PW; Glass JI; Rappuoli R; Venter JC
Sci Transl Med; 2013 May; 5(185):185ra68. PubMed ID: 23677594
[TBL] [Abstract][Full Text] [Related]
20. Construction and comparison of different source neuraminidase candidate vaccine strains for human infection with Eurasian avian-like influenza H1N1 virus.
Liu L; Lu J; Zhou J; Li Z; Zhang H; Wang D; Shu Y
Microbes Infect; 2017 Dec; 19(12):635-640. PubMed ID: 28859895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
